Headquarters: Irving, TX, United States
Founded: New York City, United States1833
CEO: Mr. Brian S. Tyler Ph.D.
USD as of April 1, 2022
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021. McKesson is based in Irving, Texas, and distributes health care systems, medical supplies and pharmaceutical products. Additionally, McKesson provides extensive network infrastructure for the health care industry; also, it was an early adopter of technologies like bar-code scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit of profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson has expanded on its well-established credentials as key vaccine distributor, serving as the U.S. government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits across the United States. As of 2021, McKesson was ranked #7 on the Fortune 500 rankings of the largest United States corporations, with revenues of $238.2 billion.
Source: Wikipedia, retrieved on March 31, 2022, 9:01 p.m.
PharmaceuticalsMedical technologyHealth care services
Founder(s): John Mc Kesson Charles Olcott
Brian S. Tyler (CEO)
Revenue: US$231.051 billion (2020): 35
Operating income: US$1.120 billion (2020): 35
Net income: US$1.126 billion (2020): 35
Total assets: US$61.247 billion (2020): 35
Total equity: US$5.092 billion (2020): 35